Evidence map›Paper›PMID 35044807›Full record

ArticlemSphere2022

Synergism and Antagonism of Bacterial-Viral Coinfection in the Upper Respiratory Tract.

Sam Manna, Julie McAuley, Jonathan Jacobson, Cattram D Nguyen, Md Ashik Ullah, Ismail Sebina, Victoria Williamson, E Kim Mulholland, Odilia Wijburg, Simon Phipps and 1 more

Open access · goldAbstract read
In one paragraph

Article in mSphere, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. bioRxiv : the preprint server for biology · 2026
    Article
  5. Review
  6. [Epidemiology, Mechanisms, and Clinical Challenges of Respiratory Syncytial Virus Co-infections in Children].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Mucosal immunotherapy targeting APC in lung disease.Journal of inflammation (London, England) · 2025
    Review
  17. Article
  18. Article
  19. SARS-CoV-2 andFrontiers in cellular and infection microbiology · 2025
    Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Sam MannaInfection and Immunity, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.ORCID 0000-0002-7694-9605
Julie McAuleyDepartment of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbournegrid.1008.9, Melbourne, Victoria, Australia.
Jonathan JacobsonInfection and Immunity, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.
Cattram D NguyenInfection and Immunity, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.
Md Ashik UllahRespiratory Immunology Laboratory, QIMR Berghofer Medical Research Institutegrid.1049.c, Herston, Queensland, Australia.
Ismail SebinaRespiratory Immunology Laboratory, QIMR Berghofer Medical Research Institutegrid.1049.c, Herston, Queensland, Australia.
Victoria WilliamsonInfection and Immunity, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.
E Kim MulhollandInfection and Immunity, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.
Odilia WijburgDepartment of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbournegrid.1008.9, Melbourne, Victoria, Australia.
Simon PhippsRespiratory Immunology Laboratory, QIMR Berghofer Medical Research Institutegrid.1049.c, Herston, Queensland, Australia.
Catherine SatzkeInfection and Immunity, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.
Royal Children's Hospital · AUQIMR Berghofer Medical Research Institute · AUThe University of Melbourne · AU

Funding

Department of Health | National Health and Medical Research Council (NHMRC) GNT1021701Department of Health | National Health and Medical Research Council (NHMRC) GNT1087957Department of Health | National Health and Medical Research Council (NHMRC) GNT1182442Jack Brockhoff Foundation 4212
6 · The paper itself

Abstract

Streptococcus pneumoniae (the pneumococcus) is a leading cause of pneumonia in children under 5 years of age. Coinfection by pneumococci and respiratory viruses enhances disease severity. Little is known about pneumococcal coinfections with respiratory syncytial virus (RSV). Here, we developed a novel infant mouse model of coinfection using pneumonia virus of mice (PVM), a murine analogue of RSV, to examine the dynamics of coinfection in the upper respiratory tract, an anatomical niche that is essential for host-to-host transmission and progression to disease. Coinfection increased damage to the nasal tissue and increased production of the chemokine CCL3. Nasopharyngeal pneumococcal density and shedding in nasal secretions were increased by coinfection. In contrast, coinfection reduced PVM loads in the nasopharynx, an effect that was independent of pneumococcal strain and the order of infection. We showed that this "antagonistic" effect was absent using either ethanol-killed pneumococci or a pneumococcal mutant deficient in capsule production and incapable of nasopharyngeal carriage. Colonization with a pneumococcal strain naturally unable to produce capsule also reduced viral loads. The pneumococcus-mediated reduction in PVM loads was caused by accelerated viral clearance from the nasopharynx. Although these synergistic and antagonistic effects occurred with both wild-type pneumococcal strains used in this study, the magnitude of the effects was strain dependent. Lastly, we showed that pneumococci can also antagonize influenza virus. Taken together, our study has uncovered multiple novel facets of bacterial-viral coinfection. Our findings have important public health implications, including for bacterial and viral vaccination strategies in young children.

Indexed as

AntibiosisAge FactorsAnimalsCoinfectionCytokinesDisease Models, AnimalInfluenza A virusMiceMice, Inbred C57BLMurine pneumonia virusNasopharynxOrthomyxoviridae InfectionsPneumococcal InfectionsPneumovirus InfectionsRespiratory SystemStreptococcus pneumoniaeCytokinescoinfectioninfluenzamurine pneumonia viruspneumococcuspneumonia virus of micerespiratory syncytial virusStreptococcus pneumoniae

Identifiers

PMID35044807
PMCPMC8769199
OpenAlexW4220712537

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.